Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Net Income towards Common Stockholders: 2017-2024

Historic Net Income towards Common Stockholders for Tonix Pharmaceuticals Holding (TNXP) over the last 8 years, with Dec 2024 value amounting to -$130.0 million.

  • Tonix Pharmaceuticals Holding's Net Income towards Common Stockholders fell 125.22% to -$32.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$99.2 million, marking a year-over-year increase of 26.64%. This contributed to the annual value of -$130.0 million for FY2024, which is 11.47% down from last year.
  • Tonix Pharmaceuticals Holding's Net Income towards Common Stockholders amounted to -$130.0 million in FY2024, which was down 11.47% from -$116.7 million recorded in FY2023.
  • In the past 5 years, Tonix Pharmaceuticals Holding's Net Income towards Common Stockholders ranged from a high of -$52.2 million in FY2020 and a low of -$130.0 million during FY2024.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's median Net Income towards Common Stockholders value was -$116.9 million (recorded in 2022), while the average stood at -$121.2 million.
  • As far as peak fluctuations go, Tonix Pharmaceuticals Holding's Net Income towards Common Stockholders slumped by 76.88% in 2021, and later increased by 0.19% in 2023.
  • Yearly analysis of 5 years shows Tonix Pharmaceuticals Holding's Net Income towards Common Stockholders stood at -$52.2 million in 2020, then tumbled by 76.88% to -$92.3 million in 2021, then decreased by 26.65% to -$116.9 million in 2022, then increased by 0.19% to -$116.7 million in 2023, then dropped by 11.47% to -$130.0 million in 2024.